Antigenic cartography using sera from sequence-confirmed SARS-CoV-2 variants of concern infections reveals antigenic divergence of Omicron.
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
van der Straten, KarlijnGuerra, Denise
van Gils, Marit J
Bontjer, Ilja
Caniels, Tom G
van Willigen, Hugo D G
Wynberg, Elke
Poniman, Meliawati
Burger, Judith A
Bouhuijs, Joey H
van Rijswijk, Jacqueline
Olijhoek, Wouter
Liesdek, Marinus H
Lavell, A H Ayesha
Appelman, Brent
Sikkens, Jonne J
Bomers, Marije K
Han, Alvin X
Nichols, Brooke E
Prins, Maria
Vennema, Harry
Reusken, Chantal
de Jong, Menno D
de Bree, Godelieve J
Russell, Colin A
Eggink, Dirk
Sanders, Rogier W
Type
ArticleLanguage
en
Metadata
Show full item recordTitle
Antigenic cartography using sera from sequence-confirmed SARS-CoV-2 variants of concern infections reveals antigenic divergence of Omicron.Published in
Immunity 2022; 55(9):1725-1731.e4PMID
35973428ae974a485f413a2113503eed53cd6c53
10.1016/j.immuni.2022.07.018
Scopus Count
Collections
Related articles
- Antigenic cartography of well-characterized human sera shows SARS-CoV-2 neutralization differences based on infection and vaccination history.
- Authors: Wang W, Lusvarghi S, Subramanian R, Epsi NJ, Wang R, Goguet E, Fries AC, Echegaray F, Vassell R, Coggins SA, Richard SA, Lindholm DA, Mende K, Ewers EC, Larson DT, Colombo RE, Colombo CJ, Joseph JO, Rozman JS, Smith A, Lalani T, Berjohn CM, Maves RC, Jones MU, Mody R, Huprikar N, Livezey J, Saunders D, Hollis-Perry M, Wang G, Ganesan A, Simons MP, Broder CC, Tribble DR, Laing ED, Agan BK, Burgess TH, Mitre E, Pollett SD, Katzelnick LC, Weiss CD
- Issue date: 2022 Dec 14
- Antigenic cartography of SARS-CoV-2 reveals that Omicron BA.1 and BA.2 are antigenically distinct.
- Authors: Mykytyn AZ, Rissmann M, Kok A, Rosu ME, Schipper D, Breugem TI, van den Doel PB, Chandler F, Bestebroer T, de Wit M, van Royen ME, Molenkamp R, Oude Munnink BB, de Vries RD, GeurtsvanKessel C, Smith DJ, Koopmans MPG, Rockx B, Lamers MM, Fouchier RAM, Haagmans BL
- Issue date: 2022 Sep 23
- Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCs.
- Authors: Bekliz M, Adea K, Vetter P, Eberhardt CS, Hosszu-Fellous K, Vu DL, Puhach O, Essaidi-Laziosi M, Waldvogel-Abramowski S, Stephan C, L'Huillier AG, Siegrist CA, Didierlaurent AM, Kaiser L, Meyer B, Eckerle I
- Issue date: 2022 Jul 4
- A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants.
- Authors: Zhang J, Han ZB, Liang Y, Zhang XF, Jin YQ, Du LF, Shao S, Wang H, Hou JW, Xu K, Lei W, Lei ZH, Liu ZM, Zhang J, Hou YN, Liu N, Shen FJ, Wu JJ, Zheng X, Li XY, Li X, Huang WJ, Wu GZ, Su JG, Li QM
- Issue date: 2022 Aug 25
- Different Neutralization Profiles After Primary SARS-CoV-2 Omicron BA.1 and BA.2 Infections.
- Authors: Medits I, Springer DN, Graninger M, Camp JV, Höltl E, Aberle SW, Traugott MT, Hoepler W, Deutsch J, Lammel O, Borsodi C, Puchhammer-Stöckl E, Zoufaly A, Weseslindtner L, Aberle JH, Stiasny K
- Issue date: 2022